Gulf Coast TX
Novartis signs mRNA deal for about $7.8 billion with China's Abogen
Oct 2 (Reuters) -- Chinese biotech company Abogen said on Friday it signed a licensing deal worth about $7.8 billion with Swiss drug maker Novartis to advance RNA-based therapy. No…
